The downregulation of PROS in the ME/CFS group, along with increases in TSP-1 and PF4, further emphasize a procoagulant phenotype in this ME/CFS population, as well as dysregulated endothelial function. The gene discussed is PROS1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.